MANKIND PHARMA
|
The Current P/S Ratio of MANKIND PHARMA is 8.72.
Share Price | ₹2,459.3 | Jan 27,2025 |
Market Cap | ₹101,468.7 Cr | |
Sales-TTM | ₹11,641.0 Cr | TTM-Consolidated Results |
Price/Sales | 8.72x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of MANKIND PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹101,468.7 Cr] as on Jan 27,2025
(/) Sales [ ₹11,641.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 8.72x ]
Thus, for MANKIND PHARMA , the investors are currently willing to pay '8.72 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of MANKIND PHARMA !
The chart below summarizes the trend in P/S Ratio of MANKIND PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of MANKIND PHARMA
PS Ratio Performance Analysis for MANKIND PHARMA
- MANKIND PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.78x.
- MANKIND PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MANKIND PHARMA 's p/e ratio peaked in Mar2024 at 8.9x.
- MANKIND PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does MANKIND PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
MANKIND PHARMA | 11,641.0 | 8.72 | 101,468.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.52 | 428,461.0 |
CIPLA LTD | 26,512.0 | 4.25 | 112,735.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.20 | 99,913.9 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.32 | 92,815.0 |
DIVIS LABORATORIES LTD | 8,614.0 | 17.18 | 147,983.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.99 | 112,895.0 |
LUPIN LTD | 21,431.3 | 4.42 | 94,823.8 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.25 | 68,261.6 |
ABBOTT INDIA LTD | 6,066.1 | 9.29 | 56,379.9 |
ALKEM LABORATORIES LTD | 12,706.2 | 4.66 | 59,234.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs MANKIND PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.25x |
Max industry PS | 17.18x |
Median industry PS | 4.66x |
Average industry PS | 6.98x |
You may also like the below Video Courses